0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A multicentre, pragmatic, cluster randomised, controlled feasibility trial of the POD system of care

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          to provide a preliminary estimate of the effectiveness of the prevention of delirium (POD) system of care in reducing incident delirium in acute hospital wards and gather data for a future definitive randomised controlled trial.

          Design

          cluster randomised and controlled feasibility trial.

          Setting

          sixteen acute care of older people and orthopaedic trauma wards in eight hospitals in England and Wales.

          Participants

          patients 65 years and over admitted to participating wards during the trial period.

          Interventions

          participating wards were randomly assigned to either the POD programme or usual care, determined by existing local policies and practices. The POD programme is a manualised multicomponent delirium prevention intervention that targets 10 risk factors for delirium. The intervention wards underwent a 6-month implementation period before trial recruitment commenced. Main outcome measure incidence of new-onset delirium measured using the Confusion Assessment Method (CAM) measured daily for up to 10 days post consent.

          Results

          out of 4449, 3274 patients admitted to the wards were eligible. In total, 714 patients consented (713 registered) to the trial, thirty-three participants (4.6%) withdrew. Adherence to the intervention was classified as at least medium for seven wards. Rates of new-onset delirium were lower than expected and did not differ between groups (24 (7.0%) of participants in the intervention group versus 33 (8.9%) in the control group; odds ratio (95% confidence interval) 0.68 (0.37–1.26); P = 0.2225).

          Conclusions

          based on these findings, a definitive trial is achievable and would need to recruit 5220 patients in 26 two-ward hospital clusters.

          Trial registration: ISRCTN01187372. Registered 13 March 2014.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: not found
          • Article: not found

          An extended activities of daily living scale for stroke patients

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            What are pragmatic trials?

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Which medications to avoid in people at risk of delirium: a systematic review.

              delirium is a common clinical problem and is associated with adverse health outcomes. Many medications have been associated with the development of delirium, but the strength of the associations is uncertain and it is unclear which medications should be avoided in people at risk of delirium. we conducted a systematic review to identify prospective studies that investigated the association between medications and risk of delirium. A sensitivity analysis was performed to construct an evidence hierarchy for the risk of delirium with individual agents. a total of 18,767 studies were identified by the search strategy. Fourteen studies met the inclusion criteria. Delirium risk appears to be increased with opioids (odds ratio [OR] 2.5, 95% CI 1.2-5.2), benzodiazepines (3.0, 1.3-6.8), dihydropyridines (2.4, 1.0-5.8) and possibly antihistamines (1.8, 0.7-4.5). There appears to be no increased risk with neuroleptics (0.9, 0.6-1.3) or digoxin (0.5, 0.3-0.9). There is uncertainty regarding H(2) antagonists, tricyclic antidepressants, antiparkinson medications, steroids, non-steroidal anti-inflammatory drugs and antimuscarinics. for people at risk of delirium, avoid new prescriptions of benzodiazepines or consider reducing or stopping these medications where possible. Opioids should be prescribed with caution in people at risk of delirium, but this should be tempered by the observation that untreated severe pain can itself trigger delirium. Caution is also required when prescribing dihydropyridines and antihistamine H1 antagonists for people at risk of delirium and considered individual patient assessment is advocated.
                Bookmark

                Author and article information

                Journal
                Age Ageing
                Age Ageing
                ageing
                Age and Ageing
                Oxford University Press
                0002-0729
                1468-2834
                July 2020
                18 April 2020
                18 April 2020
                : 49
                : 4
                : 640-647
                Affiliations
                [1 ] Academic Unit for Ageing and Stroke Research , University of Leeds, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
                [2 ] Academic Unit for Ageing and Stroke Research , Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
                [3 ] Clinical Trials Research Unit , Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK
                [4 ] Hull York Medical School , University of York, York, UK
                [5 ] Bradford District Care NHS Foundation Trust , Bradford, UK
                [6 ] Beth Israel Deaconess Medical Center , Harvard Medical School, Boston, MA, USA
                [7 ] Aging Brain Center , Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA, USA
                Author notes
                Address correspondence to: John Green. Tel: +01274 383402; Email: john.green@ 123456bthft.nhs.uk
                Article
                afaa044
                10.1093/ageing/afaa044
                7331094
                32307515
                3a5d8732-cb52-4eb4-97e5-b3164283a514
                © The Author(s) 2020. Published by Oxford University Press on behalf of the British Geriatrics Society.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 25 September 2019
                : 14 December 2019
                Page count
                Pages: 8
                Funding
                Funded by: National Institute for Health Research, DOI 10.13039/501100000272;
                Award ID: RP-PG-0108-10037
                Funded by: National Institute on Aging, DOI 10.13039/100000049;
                Award ID: R24AG054259
                Categories
                AcademicSubjects/MED00280
                Research Paper

                Geriatric medicine
                delirium,hospitals,multicomponent interventions,older people,prevention
                Geriatric medicine
                delirium, hospitals, multicomponent interventions, older people, prevention

                Comments

                Comment on this article